Home
Newsletter
Events
Blogs
Reports
Graphics
RSS
About Us
Support
Write for Us
Media Info
Advertising Info
Health news

Medscape review supports effectiveness and safety of new non-drug blood pressure treatment (press release)

Friday, October 06, 2006 by: NewsTarget
Tags: health news, Natural News, nutrition


Most Viewed Articles
https://www.naturalnews.com/020673_blood_pressure_treatment.html
Delicious
diaspora
Print
Email
Share

InterCure, Ltd., today announced the publication of a peer-reviewed clinical overview of seven clinical trials evaluating the efficacy of device-guided breathing. The study's authors conclude that RESPeRATE, an FDA-cleared over-the-counter therapeutic device, is an effective non-pharmacologic treatment option for treating hypertension with no side effects.

The article, published in the General Medicine Journal (http://www.medscape.com/viewarticle/539099) of Medscape (NASDAQ:WBMD), is authored by William J. Elliott, MD, PhD, professor of Preventive Medicine, Internal Medicine and Pharmacology at Rush Medical College, Ill., and Joseph L. Izzo, Jr., MD, professor of medicine and vice chair of Medical Research at the University of Buffalo, N.Y.

The article confirms the body of evidence from seven published clinical studies concluding that routine use of RESPeRATE, either alone or as an adjunctive treatment with lifestyle modifications or prescription drugs, significantly lowered blood pressure with no adverse side effects. The study also reviews the physiological mechanism of action of device-guided breathing.

A summary of the results of the seven studies shows an average all-day reduction of 14/8 mm Hg within four to six weeks of commencement of 15-minute-daily treatments with RESPeRATE. The reduction in blood pressure was consistent between studies, whether measurements were taken in the home, 24-hour ambulatory setting or physician's office. Larger blood pressure reductions were seen in older individuals and those with higher baseline readings, regardless of whether they were also being treated with prescription antihypertensive medications.

The authors summarize the patient populations for whom device-guided breathing appears to be beneficial: (1) prehypertensives and white-coat or labile hypertensives who might benefit from reducing stress and sympathetic activity; (2) patients with isolated systolic hypertension; and (3) patients with resistant hypertension (uncontrolled blood pressure despite use of a diuretic and at least two other medications at maximum approved doses).

"When I was first introduced to RESPeRATE, I was skeptical, but after seven trials, the body of data speaks for itself. I have seen first-hand that as long as patients use the device regularly, blood pressure is reduced, with no side effects," says Dr. William Elliott, Rush Medical Center. "Controlling hypertension requires a comprehensive approach, and device-guided breathing provides an additional effective therapeutic modality to offer our patients."

More than 65 million Americans have high blood pressure, and even with traditional treatment methods of diet, exercise and medication, 70 percent of that population is either unable to reach their lower blood pressure goals or can't tolerate the side effects of medications. Left untreated, high blood pressure may lead to heart attack, stroke and kidney or heart failure.

Contact: Jane Hauser [email protected] 781-684-0770 Schwartz Communications


Receive Our Free Email Newsletter

Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.


comments powered by Disqus



Natural News Wire (Sponsored Content)

Science.News
Science News & Studies
Medicine.News
Medicine News and Information
Food.News
Food News & Studies
Health.News
Health News & Studies
Herbs.News
Herbs News & Information
Pollution.News
Pollution News & Studies
Cancer.News
Cancer News & Studies
Climate.News
Climate News & Studies
Survival.News
Survival News & Information
Gear.News
Gear News & Information
Glitch.News
News covering technology, stocks, hackers, and more